Third Molar Extraction and Persistent Use of Opioids

Abstract

Dr Brummett reported holding a patent for peripheral perineural dexmedetomidine licensed to University of Michigan, being a consultant for Recro Pharma and Heron Therapeutics, and previously receiving research funding from Neuros Medical. No other disclosures were reported.

Posttraumatic Density of the Bone Tissue of the Rat’s Mandible Without Pathology, on the Background of Nalbuphine Intake and After Lincomycin Treatment

“…The reason of the most common causes of patients' referral to the clinic of maxillofacial surgery include jaw injury with the break of bone integrity [1,3,6,9,12]. Data from numerous scientific studies indicate that there are many factors that affect the course of reparative osteogenesis -concomitant or background diseases, bad habits, patient's age, alcohol or drug dependence [7,8,10,11,12,13,14,15,16]. Various types of drug correction are widely used for correction and optimization of bone tissue reconstruction after bone-traumatic injury [13,15,16,17,18].…”